CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy

The 19th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s cancer immunotherapy meeting, was the first in-person event organized by CIMT since the beginning of the COVID-19 pandemic. As a hybrid event from May 10–12, the meeting attracted 920 academic and clinical professio...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Peer Andre, Freitag, Janina, Linkenbach, Sophie-Christin, Merz, Lukas, Schork, Maik, Thevissen, Sophia, Yildiz, Ikra, Beck, Jan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Immunotherapeutics – Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746370/
https://www.ncbi.nlm.nih.gov/pubmed/36222759
http://dx.doi.org/10.1080/21645515.2022.2124785
Descripción
Sumario:The 19th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s cancer immunotherapy meeting, was the first in-person event organized by CIMT since the beginning of the COVID-19 pandemic. As a hybrid event from May 10–12, the meeting attracted 920 academic and clinical professionals from over 40 countries, who met to discuss the latest advances in cancer immunology and immunotherapy research. This report summarizes the highlights of CIMT2022.

Ejemplares similares